December 27, 2024

11 Medical Breakthroughs This Year

Explore medical breakthroughs from 2024, including advancements in Parkinson’s therapy, ulcerative colitis treatments, and gene therapy for hereditary deafness.

Conexiant

December 26, 2024

Study: COVID Hits Kidneys Harder Than Pneumonia

Researchers recommend closer monitoring of kidney function in hospitalized COVID-19 patients to enable early detection and management of chronic kidney disease.

Conexiant

December 23, 2024

ACC Issues New Post-Stroke Monitoring Guidelines

The American College of Cardiology releases a consensus document providing specific guidance for cardiac monitoring after stroke, outlining distinct approaches and recommendations based on stroke etiology.

Conexiant

December 19, 2024

Large Acetaminophen Study Reveals New Risks

In a large cohort study of 180,483 acetaminophen users aged 65 or older, researchers found that use was associated with a 36% increased risk of lower gastrointestinal bleeding.

Conexiant

December 18, 2024

Physicians With Kids Face Large Pay Gaps

Physician compensation remains a central concern in health care, influenced by educational debt, specialty-specific variations, and evolving employer policies.

Conexiant

December 11, 2024

Magnesium Deficiency Linked to MAFLD Risk

A recent study found that severe magnesium deficiency raises the odds of metabolic dysfunction-associated fatty liver disease significantly, highlighting the importance of comprehensive measures for evaluating deficiency and its clinical implications.

Conexiant

December 10, 2024

ASCVD Risk Elevated in Cutaneous Lupus

Recent study in JAMA Dermatology shows patients with cutaneous lupus erythematosus have a 72% higher risk of developing atherosclerotic cardiovascular disease, emphasizing the need for targeted screening and management.

Conexiant

December 10, 2024

Biomarkers in Familial Mediterranean Fever: Therapy Insights

A recent study on familial Mediterranean fever revealed that nearly 56% of heterozygous patients who stopped colchicine therapy sustained remission with lower levels of specific biomarkers, highlighting the potential of personalized treatment for FMF patients.

Conexiant

December 09, 2024

Do SGLT2i, GLP-1 RAs Cut Pneumonia, Sepsis Risk?

In the largest real-world study to date, GLP-1 receptor agonists reduced pneumonia risk by 40% in type 2 diabetes patients.

Conexiant